The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy

BACKGROUND: Tyrosine-kinase inhibitor (TKI) targeting angiogenesis improves the prognosis of patients with metastatic renal cell carcinoma (RCC), but its effect is temporary. In order to understand the mechanism by which RCC acquires resistance to TKI, we investigated the change of glucose accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaigawa, Noboru, Kondo, Keiichi, Ueno, Daiki, Namura, Kazuhiro, Makiyama, Kazuhide, Kobayashi, Kazuki, Shioi, Koichi, Ikeda, Ichiro, Kishida, Takeshi, Kaneta, Tomohiro, Minamimoto, Ryogo, Tateishi, Ukihide, Inoue, Tomio, Yao, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223335/
https://www.ncbi.nlm.nih.gov/pubmed/28068944
http://dx.doi.org/10.1186/s12885-016-3044-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223335/
https://www.ncbi.nlm.nih.gov/pubmed/28068944
http://dx.doi.org/10.1186/s12885-016-3044-0

Ejemplares similares